Information related to infectious disease testing policies and practices of organ procurement organizations in the United States does not currently exist.
A total of 63 organ procurement organizations in the United States were surveyed during May 1996.
Participants responded to a detailed questionnaire concerning infectious disease tests performed for tissue and solid organ donors and policies related to the reporting and notification of positive test results.
The response rate was 77.8%. The majority of testing is performed by hospital laboratories with an expected turnaround time of 5 hr or less by 71% of organ procurement organizations.
Almost all routinely perform screening tests for human immunodeficiency virus, hepatitis C virus, cytomegalovirus, syphilis, human T lymphocyte virus I, and hepatitis B surface antigen.
Other tests are performed with greater variability.
Although the majority of organ procurement organizations perform confirmatory tests when screening tests are positive, 35% do not perform confirmatory testing or do so only sporadically.
There are a wide range of policies concerning the subsequent reporting of positive infectious disease tests and to whom results should be reported.
Mots-clés Pascal : Banque organe, Exploration microbiologique, Infection, Organe, Tissu, Pratique professionnelle, Interprétation test, Etats Unis, Amérique du Nord, Amérique, Donneur
Mots-clés Pascal anglais : Organ bank, Microbiological investigation, Infection, Organ, Tissue, Professional practice, Test interpretation, United States, North America, America, Donor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0385536
Code Inist : 002B27C. Création : 12/09/1997.